Open AccessTeneligliptin in Early Diabetic Kidney Disease: An Observation in Asian Indian Patients with Type 2 Diabetes Mellitus in Real-Life Scenario
Author(s) -
Kiran Shah
Publication year - 2017
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2017/27013.10003
Subject(s) - medicine , renal function , gastroenterology , postprandial , type 2 diabetes mellitus , diabetes mellitus , creatinine , type 2 diabetes , kidney disease , statistical significance , diabetic retinopathy , dipeptidyl peptidase 4 inhibitor , lipid profile , urology , endocrinology
Teneligliptin is a recently developed Dipeptidyl Peptidase 4 (DPP4) inhibitor. Teneligliptin is suitable for glycaemic control with renal impairment including end stage renal disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom